NEXOSOME ONCOLOGY
Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.
NEXOSOME ONCOLOGY
Industry:
Health Care Health Diagnostics
Founded:
2021-01-01
Address:
Lexington, Kentucky, United States
Country:
United States
Website Url:
http://www.nexosome-oncology.com
Status:
Active
Total Funding:
3.65 M USD
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Illumina Accelerator
Illumina Accelerator is a company creation engine focused on building breakthrough genomics startups!
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Current Advisors List
Current Employees Featured
Investors List
OCA Ventures
OCA Ventures investment in Seed Round - Nexosome Oncology
Keyhorse Capital (KSTC)
Keyhorse Capital (KSTC) investment in Seed Round - Nexosome Oncology
VisionTech Partners
VisionTech Partners investment in Seed Round - Nexosome Oncology
Official Site Inspections
http://www.nexosome-oncology.com
Unable to get host informations!!!
More informations about "Nexosome Oncology"
Nexosome Oncology - Crunchbase Company Profile & Funding
Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field. A service that analyzes over three dozen biomarkers from blood-derived exosomes to identify …See details»
Nexosome Oncology - LinkedIn
Novel Diagnostic Proteomics Platform for Cancer | Nexosome Oncology is a company based out of Durham, NC.See details»
Nexosome Oncology - PitchBook
Developer of exosome-based diagnostics intended for various cancer detection. The company specializes in tumor monitoring, along with blood-derived exosomes that are useful to assess …See details»
Copy of NxOnc website
HIGH ACCURACY AND REPRODUCIBILITY. Early detection of cancer from liquid biopsies, avoiding need for tissue biopsiesSee details»
Todd Hembrough - Chief Executive Officer - Nexosome …
Co-founder and CEO of extracellular vesicle proteomics based liquid biopsy company. We are innovating the liquid biopsy space by taking an unbiased …See details»
Nexosome Oncology - Funding, Financials, Valuation & Investors
Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.See details»
Nexosome Oncology raises $4M in seed round — here are the …
Jan 10, 2022 · Nexosome Oncology raised $4 million in the round, which wrapped up at the end of 2021. The startup, led by CEO Todd Hembrough, is the third venture to spin out of NX …See details»
Nexosome Oncology - Contacts, Employees, Board Members
Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.See details»
Nexosome Oncology - Products, Competitors, Financials, …
Nexosome Oncology focuses on advanced tumor intelligence within the biotechnology sector. Use the CB Insights Platform to explore Nexosome Oncology's full profile.See details»
Nexosome Oncology - VisionTech Partners
Nexosome Oncology is focused on the applications of exosome-based diagnostics in the cancer field. Findings to date confirm that employing an exosome-focused liquid biopsy approach to …See details»
Nexosome Oncology raises $4M in seed round
Jan 12, 2022 · Nexosome Oncology, incorporated in 2021, is the final spinout of NX PharmaGen, Saunders said. It is focused on the applications of exosome-based diagnostics in the cancer field and will use the $4 million investment to …See details»
Nexosome Oncology - Crunchbase
Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.See details»
Todd Hembrough, PhD, CEO and Co-Founder Nexosome Oncology
Todd Hembrough, PhD, CEO and Co-Founder Nexosome Oncology Title: Identification of early-stage NSCLC biomarkers from extracellular vesicle microenvironment identifies tumor and …See details»
NX Pharmagen - Craft
NX Pharmagen is a company that acquires, develops, and monetizes mature clinical-stage technologies. It offers NeXosome, a platform that utilizes a blood-based proteomic …See details»
Nexosome Oncology on LinkedIn: Exciting Announcement from …
Exciting Announcement from Nexosome Oncology! ? We're thrilled to share our groundbreaking research in collaboration with Biognosys being showcased in a poster presentation at the …See details»
Nexosome Oncology - Tech Stack, Apps, Patents & Trademarks
Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.See details»
Nexosome Oncology - Updates, News, Events, Signals & Triggers
Nov 22, 2021 · Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.See details»
Nexosome Oncology on LinkedIn: #aacr #cancerresearch …
Exciting Announcement from Nexosome Oncology! ? We're thrilled to share our groundbreaking research in collaboration with Biognosys being showcased in a poster presentation at the …See details»
Nexosome Oncology | Exosome RNA
Jan 12, 2022 · A spin-out of a Louisville-based health care company has closed on a rather large fundraising seed round. Nexosome Oncology raised $4 million in the round, which wrapped up …See details»
Seed Round - Nexosome Oncology - 2021-11-22 - Crunchbase
Nexosome Oncology raised $3652126 on 2021-11-22 in Seed Round. Start Free TrialSee details»